Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Clopidogrel Krka“
Suchtreffer
Begriffe & Kennungen
Clopidogrel Krka d.d. (previously Zopya) · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel Krka d.d. (previously Zopya) · 4.8 · In CLARITY, there was an overall increase in bleeding in the clopidogrel plus ASA group vs. the placebo plus A
Eintrag öffnenClopidogrel Krka d.d. (previously Zopya) · 4.8 · In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both gro
Eintrag öffnenClopidogrel Krka d.d. (previously Zopya) · 4.8 · In CURE, there was no excess in major bleeds with clopidogrel plus ASA within 7 days after coronary bypass gra
Eintrag öffnenClopidogrel Krka d.d. (previously Zopya) · 4.8 · In TARDIS, patients with recent ischemic stroke receiving intensive antiplatelet therapy with three medicinal
Eintrag öffnenClopidogrel Krka d.d. (previously Zopya) · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenClopidogrel Krka d.d. (previously Zopya) · 4.8 · Summary of the safety profile Clopidogrel has been evaluated for safety in more than 44,000 patients who have
Eintrag öffnenClopidogrel Krka d.d. (previously Zopya) · 4.8 · Tabulated list of adverse reactions Adverse reactions that occurred either during clinical studies or that wer
Eintrag öffnenClopidogrel Krka · 4.1 Therapeutic indications · 1
Eintrag öffnenClopidogrel Krka · 4.3 Contraindications · 1
Eintrag öffnenClopidogrel Krka · 4.3 · - Hypersensitivity to the active substance or to any of the excipients listed in section 2 or section 6.1. - S
Eintrag öffnenClopidogrel Krka · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenClopidogrel Krka · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenClopidogrel Krka · 4.5 · 6 NSAIDs: in a clinical study conducted in healthy volunteers, the concomitant administration of clopidogrel a
Eintrag öffnenClopidogrel Krka · 4.5 · 7 A significantly reduced platelet inhibition has been shown in HIV patients treated with ritonavir-or cobicis
Eintrag öffnenClopidogrel Krka · 4.5 · Acetylsalicylic acid (ASA): ASA did not modify the clopidogrel-mediated inhibition of ADP-induced platelet agg
Eintrag öffnenClopidogrel Krka · 4.5 · Apart from the specific medicinal product interaction information described above, interaction studies with cl
Eintrag öffnenClopidogrel Krka · 4.5 · As with other oral P2Y12 inhibitors, co-administration of opioid agonists has the potential to delay and reduc
Eintrag öffnenClopidogrel Krka · 4.5 · Boosted anti-retroviral therapy (ART): HIV patients treated with boosted anti-retroviral therapies (ART) are a
Eintrag öffnenClopidogrel Krka · 4.5 · CYP2C8 substrate medicinal products: Clopidogrel has been shown to increase repaglinide exposure in healthy vo
Eintrag öffnen